Morgan Stanley »

Rapt Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.6M 1.2M 3.05
2024-03-31 $17M 1.9M 8.98
2023-12-31 $26M 1.0M 24.85
2023-09-30 $13M 762k 16.62
2023-06-30 $17M 895k 18.67
2022-12-31 $15M 758k 19.79
2022-06-30 $22M 1.0M 20.83
2022-03-31 $23M 1.1M 21.99
2021-06-30 $0 347k 0.00
2020-12-31 $1.9M 95k 19.73
2020-09-30 $65k 2.0k 32.49
2020-06-30 $229k 7.9k 28.90
2020-03-31 $4.6k 213 21.74
2019-12-31 $81k 2.9k 27.80